These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6673211)

  • 1. Alloimmunization for induction of graft-versus-leukemia reactivity in H-2-compatible donors: critical role for incompatibility of donor and alloimmunizing strains at non-H-2 loci.
    Bortin MM; Truitt RL; Shih CY; Tempelis LD; LeFever AV; Rimm AA
    Transplant Proc; 1983 Dec; 15(4):2114-7. PubMed ID: 6673211
    [No Abstract]   [Full Text] [Related]  

  • 2. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL; Bortin MM; Rimm AA
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloimmunization and adoptive immunotherapy of leukemia.
    Truitt RL; Shih CY; Rimm AA; Tempelis LD; Bortin MM
    Transplant Proc; 1981 Dec; 13(4):1910-4. PubMed ID: 6949385
    [No Abstract]   [Full Text] [Related]  

  • 4. Graft-versus-leukemia effect in allogeneic bone marrow transplantation in mice against several radiation-induced leukemias.
    Aizawa S; Sado T; Kamisaku H; Nemoto K; Yoshida K
    Bone Marrow Transplant; 1994 Feb; 13(2):109-14. PubMed ID: 8205078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time pattern of the antileukemic effect of graft-versus-host reaction in mice.
    Boranić M; Tonković I
    Cancer Res; 1971 Aug; 31(8):1140-7. PubMed ID: 4398523
    [No Abstract]   [Full Text] [Related]  

  • 6. An MHC-compatible allogeneic bone marrow donor with a distinct role of T cell subsets in graft-versus-leukemia effect and lethal graft-versus-host disease.
    Aizawa S; Kamisaku H; Sado T
    Bone Marrow Transplant; 1995 Oct; 16(4):603-9. PubMed ID: 8528179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against graft-versus-host disease by large doses of donor CD4+ T cells: a novel approach to bone marrow transplantation.
    Heath WR; Miller JF; Sprent J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1222-4. PubMed ID: 8442095
    [No Abstract]   [Full Text] [Related]  

  • 9. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
    J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
    Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of the graft versus host reaction on the growth of syngenous sarcoma in mice].
    Shcherbakov VIa; Semenkov VF
    Biull Eksp Biol Med; 1973 Feb; 74(2):70-3. PubMed ID: 4155646
    [No Abstract]   [Full Text] [Related]  

  • 12. Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic h-2-identical immunocompetent cells.
    Bortin MM; Rimm AA; Rose WC; Saltzstein EC
    Transplantation; 1974 Sep; 18(3):280-3. PubMed ID: 4154022
    [No Abstract]   [Full Text] [Related]  

  • 13. [Increase of the GvH reaction after alloimmunization. Influence of the serologically defined determinants of the H-2 system].
    Brock J; Siegl E; Schulze HA
    Allerg Immunol (Leipz); 1982; 28(2):91-6. PubMed ID: 6182783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2 restriction of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers in mice.
    Korngold R; Sprent J
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1217-9. PubMed ID: 7022928
    [No Abstract]   [Full Text] [Related]  

  • 15. Dominant role of Mlsa antigens in the induction of unresponsiveness to non-H-2 antigens.
    Berumen L; Pritchard LL; Goutner A; Halle-Pannenko O
    Transplant Proc; 1987 Feb; 19(1 Pt 1):506-7. PubMed ID: 3152703
    [No Abstract]   [Full Text] [Related]  

  • 16. Graft versus host reaction in strains of mice identical for H-2K and H-2D antigens.
    Livnat S; Klein J
    Nat New Biol; 1973 May; 243(123):42-4. PubMed ID: 17315361
    [No Abstract]   [Full Text] [Related]  

  • 17. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dominant role of the genes of the K region in the mouse H-2 system in macrophage induction of T effectors of the graft vs host reaction].
    Anfalova TV; Galaktionov VG; Lutsan NI; Golenishchev VG; Kapinus LN
    Dokl Akad Nauk SSSR; 1984; 279(4):1016-20. PubMed ID: 6151888
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of cyclophosphamide on the ability of graft-versus-host reaction to suppress leukaemia in mice.
    Boranić M; Tonković I
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):314-20. PubMed ID: 4403351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.